查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1610886

積極植入式醫療設備的全球市場:洞察，競爭情形，市場預測:2030年

Active Implantable Medical Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

2023年主動式植入式醫療器材市場規模將達250億美元。預計到 2030 年，該市場將達到 385.7 億美元，2024 年至 2030 年的預測期間複合年增長率為 7.55%。主動植入式醫療器材市場的推動因素包括神經系統疾病（包括多發性硬化症、癲癇和慢性下背痛）病例的增加、監管部門批准的增加以及市場向微創手術的轉變。源植入式醫療器材的偏好日益增加，預計這將在2024-2030年預測期內進一步加速主動式植入式醫療器材市場的整體成長。

根據世界衛生組織 (WHO) 資料（2023 年），據報導全球有超過 180 萬人患有多發性硬化症 (MS)。多發性硬化症影響多種功能，包括認知、情緒、運動、感覺和視覺功能。當免疫系統錯誤地攻擊大腦和脊髓時就會發生這種情況。根據世界衛生組織的數據，到2024年，全球將有約5,000萬人受到癲癇的影響，使其成為全球最常見的神經系統疾病之一。

在多發性硬化症中，神經刺激器透過調節脊髓和周邊神經的神經活動來緩解痙攣和慢性疼痛等症狀。對於癲癇症，植入式或響應式神經刺激器可以透過向大腦發送有針對性的電脈衝來幫助減少癲癇發作的頻率和嚴重程度。

2022 年 12 月，雅培實驗室宣布美國食品藥物管理局 (FDA) 批准 Eterna 脊髓刺激系統，該系統被認為是可用於慢性疼痛治療​​的最小的植入式可充電脊髓刺激器。

所有上述因素預計將推動整個主動植入醫療器材市場的成長。

然而，替代設備和療法的可用性、硬體故障、軟體錯誤、電池消耗等引起的故障可能會對有源植入醫療設備市場的成長帶來課題。

本報告提供全球積極植入式醫療設備市場相關調查，提供市場概要，以及各產品類型，各終端用戶，各地區趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 積極植入式醫療設備市場報告的簡介

第2章 積極植入式醫療設備市場摘要整理

第3章 競爭情形

第4章 法規分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第5章 積極植入式醫療設備市場主要原因分析

  • 積極植入式醫療設備的市場促進因素
  • 積極植入式醫療設備的市場阻礙因素與課題
  • 積極植入式醫療設備的市場機會

第6章 積極植入式醫療設備市場波特的五力分析

第7章 積極植入式醫療設備市場評估

  • 各產品類型
  • 各終端用戶
  • 各地區

第8章 積極植入式醫療設備市場企業及產品簡介

  • Medtronic
  • Abbott
  • Jarvik Heart, Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • LivaNova, Inc.
  • Advanced Bionics AG
  • MicroTransponder Inc.
  • Axonics Modulation Technologies, Inc.
  • Amplifon
  • MED-EL Medical Electronics.
  • NeuroPace, Inc.
  • NEVRO CORP.
  • MEDICO S.p.A.
  • Aleva Neurotherapeutics S.A.
  • Second Sight
  • Cochlear Ltd.
  • Sonova
  • Berlin Heart GmbH
  • SynCardia Systems LLC

第9章 KOL的見解

第10章 計劃的方法

第11章 關於DelveInsight

第12章 免責聲明和諮詢方式

Product Code: DIMDCL0465

Active Implantable Medical Devices Market by Product Type (Implantable Cardiovascular Devices [Implantable Cardioverter Defibrillators, Ventricular Assist Devices, Implantable Pacemakers, and Implantable Cardiac Monitors/Insertable Loop Recorders], Implantable Neurostimulators [Deep Brain Stimulators, Spinal Cord Stimulators, Sacral Nerve Stimulators, and Others] Hearing Implants, and Others), End-User (Hospitals, Ambulatory Surgical Centres, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing instances of chronic disorders and the rising product developmental activities across the world

The active implantable medical devices market was valued at USD 25 billion in 2023, growing at a CAGR of 7.55% during the forecast period from 2024 to 2030 to reach USD 38.57 billion by 2030. The active implantable medical devices market is observing substantial market growth primarily owing to the increasing instances of chronic disorders like neurological disorders including multiple sclerosis, epilepsy, chronic lower back pain, increasing regulatory approvals, and the rising preference for minimally invasive procedures that are anticipated to further accelerate the overall growth of the active implantable medical devices market during the forecast period from 2024 to 2030.

Active Implantable Medical Devices Market Dynamics:

As per data from the World Health Organization (WHO) (2023), it was reported that over 1.8 million people worldwide are affected by multiple sclerosis (MS). It impacts various functions including cognitive, emotional, motor, sensory, and visual abilities. It occurs when the immune system mistakenly attacks the brain and spinal cord. Data from the WHO stated that in 2024, around 50 million people worldwide had epilepsy, making it one of the most common neurological diseases globally.

In MS, neurostimulators are used to alleviate symptoms such as spasticity and chronic pain by modulating neural activity in the spinal cord or peripheral nerves. For epilepsy, implantable neurostimulators and responsive neurostimulation devices help reduce the frequency and severity of seizures by delivering targeted electrical impulses to the brain.

As per the data from WHO (2023), in 2020, there were 619 million cases of lower back pain and it is projected that the number of lower back pain cases will rise to 843 million by 2050.

Data from the European Pain Federation (2023), stated that 740 million people globally experience an episode of severe pain at some point in their lives on average. For approximately 20% of these individuals, the pain persists for longer than three months, thereby categorizing it as chronic pain. Active implantable medical devices like spinal cord and peripheral nerve stimulators manage chronic and severe pain by delivering targeted electrical stimulation to disrupt pain signals, offering personalized, non-opioid pain relief and improving quality of life.

Additionally, in December 2022, Abbott Laboratories announced the U.S. Food and Drug Administration (FDA) approval for the Eterna spinal cord stimulation system, which was recognized as the smallest implantable, rechargeable spinal cord stimulator that is available for the treatment of chronic pain.

Therefore, all the factors stated above collectively will drive the overall active implantable medical devices market growth.

However, the availability of alternative devices & therapy, malfunction due to hardware failure, software errors, or battery depletion, among others may prove to be challenging factors for the active implantable medical devices market growth.

Active Implantable Medical Devices Market Segment Analysis:

Active Implantable Medical Devices Market by Product Type (Implantable Cardiovascular Devices [Implantable Cardioverter Defibrillators, Ventricular Assist Devices, Implantable Pacemakers, and Implantable Cardiac Monitors/Insertable Loop Recorders], Implantable Neurostimulators [Deep Brain Stimulators, Spinal Cord Stimulators, Sacral Nerve Stimulators, and Others] Hearing Implants, and Others), End-User (Hospitals, Ambulatory Surgical Centres, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the active implantable medical devices market, the implantable neurostimulators category is expected to have a significant revenue share in the year 2023. This can be ascribed to various key features and advantages offered by these devices.

Key features of these devices include precise, programmable stimulation settings that allow for personalized therapy adjustments, rechargeable, and minimally invasive implantation procedures. Advantages include targeted symptom relief, reduced dependency on medications, improved quality of life, and the ability to make real-time adjustments through external controllers. Additionally, many modern neurostimulators offer remote monitoring and adaptive stimulation, which automatically adjusts to the patient's activity level, enhancing treatment efficacy and patient comfort.

Moreover, new product approvals are likely to upsurge the market for the same. For example, in August 2023, Medtronic announced that it received CE Mark approval for the Inceptiv closed-loop rechargeable spinal cord stimulator implant.

Therefore the various features and advantages of implantable neurostimulators solidify the significant impact on the growth of the overall active implantable medical devices market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall active implantable medical devices market:

Among all the regions, North America is expected to dominate the active implantable medical devices market in the year 2023 and is expected to do the same during the forecast period from 2024 to 2030. This can be attributed to several factors, including the increasing prevalence of hearing loss, the growing burden of cardiovascular disorders in the region including myocardial infarction, and ongoing product developmental activities by regulatory bodies that are acting as key factors contributing to the growth of the active implantable medical devices market in the North America region.

As per data from WHO (2024), in 2021, 217 million people were living with hearing loss in the US. The same source further stated that by 2050, 322 million people would be affected by hearing problems in the US. Active implantable medical devices, such as cochlear implants, play a crucial role in managing hearing loss by directly stimulating the auditory nerve and bypassing damaged parts of the ear to restore hearing function.

According to data from the Centers for Disease Control and Prevention (2024), it was stated that 805,000 people in the US have a myocardial infarction (heart attack) every year on average. Also, data from the Canadian Institute for Health Information (2024), stated that in 2022, 2.4 million Canadians were affected by heart disease. Active implantable medical devices are critical in managing heart disease and myocardial infarction by providing real-time monitoring, regulating heart rhythm, and preventing life-threatening cardiac events. In individuals with heart attacks, devices like implantable cardioverter defibrillators and pacemakers help detect abnormal heart rhythms and restore normal function, reducing the risk of sudden cardiac arrest.

Product developmental activities initiated by regulatory bodies will further boost the market for active implantable medical devices. For example, in June 2024, Elutia Inc., a pioneer in drug-eluting biomatrix products, announced that Antibiotic-Eluting BioEnvelope, EluPro (previously known as CanGaroo during development), received clearance from the U.S. Food and Drug Administration (FDA). Designed to prevent post-operative complications for devices like implantable pacemakers and defibrillators, EluPro integrated potent antibiotic therapy with advanced tissue engineering.

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American active implantable medical devices market.

Active Implantable Medical Devices Market key players:

Some of the key market players operating in the active implantable medical devices market include Medtronic, Abbott, Jarvik Heart, Inc., Biotronik SE & Co. KG, Boston Scientific Corporation, LivaNova, Inc., Advanced Bionics AG, MicroTransponder Inc., Axonics Modulation Technologies, Inc., Amplifon, MED-EL Medical Electronics., NeuroPace, Inc., NEVRO CORP., MEDICO S.p.A., Aleva Neurotherapeutics S.A., Second Sight, Cochlear Ltd., Sonova, Berlin Heart GmbH, SynCardia Systems LLC, and others.

Recent Developmental Activities in the Active Implantable Medical Devices Market:

  • In November 2022, Cochlear Limited announced that the Cochlear Nucleus 8 Sound Processor received approval from the US Food and Drug Administration (FDA). The Nucleus 8 Sound Processor was described as the smallest and lightest behind-the-ear cochlear implant sound processor available in the industry.
  • In August 2021, MicroTransponder secured approval from the US FDA for its Vivistim Paired VNS System, a drug-free, implantable stroke rehabilitation system to treat moderate to severe upper extremity motor deficits associated with chronic ischemic stroke.
  • In June 2021, Medtronic received the US FDA approval for its spinal cord stimulation implant Vanta, used for chronic pain. It is a non-rechargeable device promising nearly double the battery life of previous hardware.

Key Takeaways from the Active Implantable Medical Devices Market Report Study

  • Market size analysis for current active implantable medical devices market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the active implantable medical devices market.
  • Various opportunities available for the other competitors in the active implantable medical devices market space
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current active implantable medical devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for active implantable medical devices market growth in the coming future?

Target Audience who can be benefited from this Active Implantable Medical Devices Market Report Study

  • Active implantable medical devices product providers
  • Research organizations and consulting companies
  • Active implantable medical devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in active implantable medical devices
  • Various end-users who want to know more about the active implantable medical devices market and the latest technological developments in the active implantable medical devices market

Frequently Asked Questions for the Active Implantable Medical Devices Market:

1. What are Active Implantable Medical Devices?

Active implantable medical devices are intended to be totally or partially introduced into the human body for diagnostic or therapeutic purposes and are to remain in place. It includes a wide range of devices, including pacemakers, defibrillators, infusion pumps, ventricular assist systems and devices, cochlear implants, and neurostimulators.

2. What is the market for Active Implantable Medical Devices?

The active implantable medical devices market was valued at USD 25 billion in 2023, growing at a CAGR of 7.55% during the forecast period from 2024 to 2030 to reach USD 38.57 billion by 2030.

3. What are the drivers for the Active Implantable Medical Devices market?

The active implantable medical devices market is observing substantial market growth primarily owing to the increasing instances of chronic disorders like neurological disorders including multiple sclerosis, epilepsy, chronic lower back pain, increasing regulatory approvals, and the rising preference for minimally invasive procedures that are anticipated to further accelerate the overall growth of the active implantable medical devices market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Active Implantable Medical Devices market?

Some of the key market players operating in active implantable medical devices include Medtronic, Abbott, Jarvik Heart, Inc., Biotronik SE & Co. KG, Boston Scientific Corporation, LivaNova, Inc., Advanced Bionics AG, MicroTransponder Inc., Axonics Modulation Technologies, Inc., Amplifon, MED-EL Medical Electronics., NeuroPace, Inc., NEVRO CORP., MEDICO S.p.A., Aleva Neurotherapeutics S.A., Second Sight, Cochlear Ltd., Sonova, Berlin Heart GmbH, SynCardia Systems LLC, and others.

5. Which region has the highest share in the Active Implantable Medical Devices market?

North America is expected to dominate the overall Active Implantable Medical Devices market during the forecast period from 2024 to 2030. This can be attributed to several factors, including the increasing prevalence of hearing loss, the growing burden of cardiovascular disorders in the region including myocardial infarction, and ongoing product developmental activities by regulatory bodies that are acting as key factors contributing to the growth of the active implantable medical devices market in the North America region.

Table of Contents

1. Active Implantable Medical Devices Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Active Implantable Medical Devices Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Active Implantable Medical Devices Market Key Factors Analysis

  • 5.1. Active Implantable Medical Devices Market Drivers
    • 5.1.1. Increasing instances of chronic disorders
    • 5.1.2. Rising product developmental activities
    • 5.1.3. Increasing patient preference for minimally invasive procedures
  • 5.2. Active Implantable Medical Devices Market Restraints and Challenges
    • 5.2.1. Availability of alternative devices and therapy
    • 5.2.2. Malfunction due to hardware failure, software errors, or battery depletion
  • 5.3. Active Implantable Medical Devices Market Opportunities
    • 5.3.1. Miniaturization and improved aesthetics
    • 5.3.2. Development of biocompatible, biodegradable, and more durable materials

6. Active Implantable Medical Devices Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Active Implantable Medical Devices Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Implantable Cardiovascular Devices
      • 7.1.1.1. Implantable Cardioverter Defibrillators
      • 7.1.1.2. Ventricular Assist Devices
      • 7.1.1.3. Implantable Pacemakers
      • 7.1.1.4. Implantable Heart Monitors/Insertable Loop Recorders
    • 7.1.2. Implantable Neurostimulators
      • 7.1.2.1. Deep Brain Stimulators
      • 7.1.2.2. Spinal Cord Stimulators
      • 7.1.2.3. Sacral Nerve Stimulators
      • 7.1.2.4. Others
    • 7.1.3. Hearing Implants
    • 7.1.4. Others
  • 7.2. By End-User
    • 7.2.1. Hospitals
    • 7.2.2. Ambulatory Surgical Centres
    • 7.2.3. Others
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Active Implantable Medical Devices Market Size in USD million (2021-2030)
      • 7.3.1.2. Canada Active Implantable Medical Devices Market Size in USD million (2021-2030)
      • 7.3.1.3. Mexico Active Implantable Medical Devices Market Size in USD million (2021-2030)
    • 7.3.2. Europe
      • 7.3.2.1. France Active Implantable Medical Devices Market Size in USD million (2021-2030)
      • 7.3.2.2. Germany Active Implantable Medical Devices Market Size in USD million (2021-2030)
      • 7.3.2.3. United Kingdom Active Implantable Medical Devices Market Size in USD million (2021-2030)
      • 7.3.2.4. Italy Active Implantable Medical Devices Market Size in USD million (2021-2030)
      • 7.3.2.5. Spain Active Implantable Medical Devices Market Size in USD million (2021-2030)
      • 7.3.2.6. Rest of Europe Active Implantable Medical Devices Market Size in USD million (2021-2030)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Active Implantable Medical Devices Market Size in USD million (2021-2030)
      • 7.3.3.2. Japan Active Implantable Medical Devices Market Size in USD million (2021-2030)
      • 7.3.3.3. India Active Implantable Medical Devices Market Size in USD million (2021-2030)
      • 7.3.3.4. Australia Active Implantable Medical Devices Market Size in USD million (2021-2030)
      • 7.3.3.5. South Korea Active Implantable Medical Devices Market Size in USD million (2021-2030)
      • 7.3.3.6. Rest of Asia-Pacific Active Implantable Medical Devices Market Size in USD million (2021-2030)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Active Implantable Medical Devices Market Size in USD million (2021-2030)
      • 7.3.4.2. Africa Active Implantable Medical Devices Market Size in USD million (2021-2030)
      • 7.3.4.3. South America Active Implantable Medical Devices Market Size in USD million (2021-2030)

8. Active Implantable Medical Devices Market Company and Product Profiles

  • 8.1. Medtronic
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Abbott
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Jarvik Heart, Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Biotronik SE & Co. KG
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Boston Scientific Corporation
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. LivaNova, Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Advanced Bionics AG
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. MicroTransponder Inc.
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Axonics Modulation Technologies, Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Amplifon
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. MED-EL Medical Electronics.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. NeuroPace, Inc.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. NEVRO CORP.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. MEDICO S.p.A.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Aleva Neurotherapeutics S.A.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Second Sight
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Cochlear Ltd.
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Sonova
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Berlin Heart GmbH
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. SynCardia Systems LLC
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Active Implantable Medical Devices Market in Global (2021-2030)
  • Table 3: Active Implantable Medical Devices Market in Global by Product Type (2021-2030)
  • Table 4: Active Implantable Medical Devices Market in Global by End-User (2021-2030)
  • Table 5: Active Implantable Medical Devices Market in Global by Geography (2021-2030)
  • Table 6: Active Implantable Medical Devices Market in North America (2021-2030)
  • Table 7: Active Implantable Medical Devices Market in the United States (2021-2030)
  • Table 8: Active Implantable Medical Devices Market in Canada (2021-2030)
  • Table 9: Active Implantable Medical Devices Market in Mexico (2021-2030)
  • Table 10: Active Implantable Medical Devices Market in Europe (2021-2030)
  • Table 11: Active Implantable Medical Devices Market in France (2021-2030)
  • Table 12: Active Implantable Medical Devices Market in Germany (2021-2030)
  • Table 13: Active Implantable Medical Devices Market in United Kingdom (2021-2030)
  • Table 14: Active Implantable Medical Devices Market in Italy (2021-2030)
  • Table 15: Active Implantable Medical Devices Market in Spain (2021-2030)
  • Table 16: Active Implantable Medical Devices Market in the Rest of Europe (2021-2030)
  • Table 17: Active Implantable Medical Devices Market in Asia-Pacific (2021-2030)
  • Table 18: Active Implantable Medical Devices Market in China (2021-2030)
  • Table 19: Active Implantable Medical Devices Market in Japan (2021-2030)
  • Table 20: Active Implantable Medical Devices Market in India (2021-2030)
  • Table 21: Active Implantable Medical Devices Market in Australia (2021-2030)
  • Table 22: Active Implantable Medical Devices Market in South Korea (2021-2030)
  • Table 23: Active Implantable Medical Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 24: Active Implantable Medical Devices Market in the Rest of the World (2021-2030)
  • Table 25: Active Implantable Medical Devices Market in the Middle East (2021-2030)
  • Table 26: Active Implantable Medical Devices Market in Africa (2021-2030)
  • Table 27: Active Implantable Medical Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Active Implantable Medical Devices Market in Global (2021-2030)
  • Figure 3: Active Implantable Medical Devices Market in Global by Product Type (2021-2030)
  • Figure 4: Active Implantable Medical Devices Market in Global by End-User (2021-2030)
  • Figure 5: Active Implantable Medical Devices Market in Global by Geography (2021-2030)
  • Figure 6: Active Implantable Medical Devices Market in North America (2021-2030)
  • Figure 7: Active Implantable Medical Devices Market in the United States (2021-2030)
  • Figure 8: Active Implantable Medical Devices Market in Canada (2021-2030)
  • Figure 9: Active Implantable Medical Devices Market in Mexico (2021-2030)
  • Figure 10: Active Implantable Medical Devices Market in Europe (2021-2030)
  • Figure 11: Active Implantable Medical Devices Market in France (2021-2030)
  • Figure 12: Active Implantable Medical Devices Market in Germany (2021-2030)
  • Figure 13: Active Implantable Medical Devices Market in United Kingdom (2021-2030)
  • Figure 14: Active Implantable Medical Devices Market in Italy (2021-2030)
  • Figure 15: Active Implantable Medical Devices Market in Spain (2021-2030)
  • Figure 16: Active Implantable Medical Devices Market in the Rest of Europe (2021-2030)
  • Figure 17: Active Implantable Medical Devices Market in Asia-Pacific (2021-2030)
  • Figure 18: Active Implantable Medical Devices Market in China (2021-2030)
  • Figure 19: Active Implantable Medical Devices Market in Japan (2021-2030)
  • Figure 20: Active Implantable Medical Devices Market in India (2021-2030)
  • Figure 21: Active Implantable Medical Devices Market in Australia (2021-2030)
  • Figure 22: Active Implantable Medical Devices Market in South Korea (2021-2030)
  • Figure 23: Active Implantable Medical Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 24: Active Implantable Medical Devices Market in the Rest of the World (2021-2030)
  • Figure 25: Active Implantable Medical Devices Market in the Middle East (2021-2030)
  • Figure 26: Active Implantable Medical Devices Market in Africa (2021-2030)
  • Figure 27: Active Implantable Medical Devices Market in South America (2021-2030)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Marker Opportunities
  • Figure 31: PORTER'S Five Force Analysis